Pharmacological Treatment of Mild Cognitive Impairment as a Prodromal Syndrome of Alzheimer's Disease

E-ISSN： 1875-6190|11|1|102-108

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.11, Iss.1, 2013-01, pp. : 102-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Treatment of Cognitive Symptoms in Alzheimer's Disease

Current Psychopharmacology, Vol. 3, Iss. 1, 2014-04 ,pp. : 59-66

Bentham Science Publishers

Access to resources Recommend Favorite

Few pharmacological options available for treating cognitive impairment associated with severe Alzheimer's disease

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 25, Iss. 10, 2009-10 ,pp. : 9-11

Adis International

Access to resources Recommend Favorite

Plasma Metabolic Profiling of Mild Cognitive Impairment and Alzheimer's Disease Using Liquid Chromatography/Mass Spectrometry

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 14, Iss. 2, 2014-09 ,pp. : 113-120

Bentham Science Publishers

Access to resources Recommend Favorite

Antioxidant Clinical Trials in Mild Cognitive Impairment and Alzheimer’s disease – Challenges and Perspectives

Current Pharmaceutical Design, Vol. 20, Iss. 18, 2014-06 ,pp. : 3083-3092

Bentham Science Publishers

Access to resources Recommend Favorite

White matter abnormalities associated with Alzheimer's disease and mild cognitive impairment: a critical review of MRI studies

By Radanovic Marcia Pereira Fabrício Ramos Silvestre Stella Florindo Aprahamian Ivan Ferreira Luiz Kobuti Forlenza Orestes Vicente Busatto Geraldo F

Expert Review of Neurotherapeutics, Vol. 13, Iss. 5, 2013-05 ,pp. : 483-493

Informa Healthcare

Access to resources Recommend Favorite